Background
==========

Recently there has been increased interest in pancreatic cholesterol esterase (CEase, EC 3.1.1.13) due to correlation between enzymatic activity in vivo and absorption of dietary cholesterol \[[@B1],[@B2]\]. Physiological substrates include cholesteryl esters, retinyl esters, triacylglycerols, vitamin esters, and phospholipids \[[@B3]-[@B5]\]. CEase plays a role in digestive lipid absorption in the upper intestinal tract, though its role in cholesterol absorption in particular is controversial \[[@B1],[@B6]\]. A recent report indicates that CEase is directly involved in lipoprotein metabolism, in that the enzyme catalyzes the conversion of large LDL to smaller, denser, more cholesteryl ester-rich lipoproteins, and that the enzyme may regulate serum cholesterol levels \[[@B7],[@B8]\]. Serine lipases, acetylcholinesterase, butyrylcholinesterase, and CEase belong to a large family of proteins called the α/β-hydrolase fold \[[@B9],[@B10]\], and they share the same catalytic machinery as serine proteases in that they have an active site serine residue which, with a histidine and an aspartic or glutamic acid, forms a catalytic triad \[[@B11],[@B12]\]. The conservation of this catalytic triad suggests that as well as sharing a common mechanism for substrate hydrolysis, that is, formation of a discrete acyl enzyme species via the active site serine hydroxy group, serine proteases, CEase, and lipases may well be expected to be inhibited by the same classes of mechanism-based inhibitors such as phosphorothiolates \[[@B13]\], pyrones \[[@B14]\], fluoroketones \[[@B15]\], boronic acids \[[@B16]\], and carbamates \[[@B16]-[@B29]\].

The crystal structure of the active site region of pancreatic CEase \[[@B30],[@B31]\] is similar to *Torpedo californica*acetylcholinesterase (AChE) \[[@B32]\], *Candida rugosa*lipase (CRL) \[[@B33],[@B34]\], *Geotrichum candidum*lipase (GCL) \[[@B35]\], and *Pseudomonas*species lipase (PSL) \[[@B36],[@B37]\]. Moreover, the active site of CEase like CRL, GCL, PSL, and acetylcholinesterase may consist of at least five major binding sites (Figure [1](#F1){ref-type="fig"}) \[[@B23],[@B24],[@B30],[@B31]\]: (a) an acyl chain binding site (ABS) that binds to the acyl chain of the substrate and is opened by the removal of C-terminal 574--579 in which is bent in shape and contains a deep, wide hole from the evacuation of Phe579, (b) an oxyanion hole (OAH), the H-bonding peptide NH functions of Gly107, Ala108, and Ala195, that stabilizes the tetrahedral species, (c) an esteratic site or the catalytic triad (ES), comprised of Ser194-His435-Asp320, that is involved in nucleophilic attack to the substrate carbonyl group and in general acid-base catalysis, and (d) a leaving group binding site (LBS) or/and the second alkyl chain or group binding site (SACS) that binds to the cholesterol part of cholesterol ester or the second fatty acid chain of triacylglycerol and is located at the opposite direction of ABS.

![Possible interactions for cholesteryl linoleate in the active site of CEase \[30,31\].](1471-2091-6-17-1){#F1}

Previous work has shown that CEase is stereoselectively inhibited by the two atropisomers (or enantiomers) of 1, 1-bi-2-naphtyl carbamates due to the stereoselective binding at LBS of the enzyme \[[@B20],[@B22]\]. Doorn et al. have also reported that CEase is stereoselectively inhibited by the four diastereomers of isomalathion due to stereoselectivity for both ES and LBS of the enzyme \[[@B13]\]. The aim of this study is to extend the stereoselectivity to the four diastereomers of inhibitors by adding two extra bonds between a chiral center and (or a chiral axis of the inhibitors. In other words, we may probe the double selectivity for both ABS and LBS of the enzyme. Thus, four diastereomers of 2\'-*N*-α-methylbenzylcarbamyl-1, 1\'-bi-2-naphthol (**1**), 2\'-*N*-(R)-α-methylbenzylcarbamyl-(R)-1, 1\'-bi-2-naphthol ((1R, αR)-**1**), 2\'-*N*-(S)-α-methylbenzylcarbamyl-(R)-1, 1\'-bi-2-naphthol ((1R, αS)-**1**), 2\'-*N*-(R)-α-methylbenzylcarbamyl-(S)-1, 1\'-bi-2-naphthol ((1S, αR)-**1**), and 2\'-*N*-(S)-α-methylbenzylcarbamyl-(S)-1, 1\'-bi-2-naphthol ((1S, αS)-**1**) (Figure [2](#F2){ref-type="fig"}), are synthesized from condensation of (R)- or (S)-1, 1\'-bi-2-naphthol with (R)-or (S)-α-methylbenzyl isocyanate in the presence of pyridine in dichloromethane. The stereoselectivity of CEase inhibition by the four diastereomers of **1**is evaluated kinetically.

![Structures of the four diastereomers of carbamates **1**and the two atropisomers of **2**.](1471-2091-6-17-2){#F2}

Most carbamate inhibitors are characterized as the pseudo substrate inhibitors of CEase (Figure [3](#F3){ref-type="fig"}) \[[@B16]-[@B29]\] and meet some of the criteria proposed by Abeles and Maycock \[[@B38]\]. First, the inhibition is time-dependent and follows pseudo-first-order kinetics; second, with increasing concentration of inhibitor the enzyme displays saturation kinetics; third, the enzyme is protected from inhibitions by carbamate by binding of a competitive inhibitor such as trifluoroacetophenone (TFA). The *K*~*i*~step leads to the tetrahedral intermediate and the *k*~2~step leads to the carbamyl enzyme intermediate. Moreover, values of *K*~*i*~and *k*~2~can be calculated from Equation 1 \[[@B16]-[@B29]\]:

![Kinetic scheme for the pseudo substrate inhibition of CEase.](1471-2091-6-17-3){#F3}

*k*~*app*~= *k*~2~\[I\]/(*K*~*i*~(1+ \[S\]/*K*~*m*~)+ \[I\]) (1)

In Equation 1, *k*~app~values are first-order rate constants which can be obtained as described in Hosie et al. \[[@B17]\]. Bimolecular rate constant, *k*~*i*~= *k*~2~/*K*~*i*~, is related to overall inhibitory potency.

Results
=======

For the first time, we synthesize four optical pure diastereomers of **1**. (1R, αR)-**1**, (1R, αS)-**1**, (1S,αR)-**1**, and (1S, αS)-**1**(Figure [2](#F2){ref-type="fig"}) are synthesized from the condensation of R-(+)- or S-(-)-1, 1\'-bi-2-naphthanol with R-(+)- or S-(-)-α-methylbenzyl isocyanate in the presence of a catalytic amount of pyridine in CH~2~Cl~2~. The \[α\]^25^~*D*~values for (1R, αR)-**1**, (1R, αS)-**1**, (1S,αR)-**1**, and (1S, αS)-**1**are +40, +21, -21, and -41°, respectively.

Like most carbamates, the four diastereomers of **1**are characterized as the pseudo substrate inhibitors of CEase (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}) and meet some of the criteria proposed by Abeles and Maycock \[[@B38]\]. When CEase is incubated with a carbamate in the presence of TFA (2 μM), a known competitive inhibitor of CEase \[[@B22]\] before the inhibition reaction, the enzyme is protected from inhibition by carbamate by binding of TFA as described in Hosie et al. \[[@B17]\] (Figure [4B](#F4){ref-type="fig"}).

![A: The *k*~*app*~vs. \[I\] plot for inhibition of the CEase-catalyzed hydrolysis of PNPB by (1R, αR)-**1**. \[PNPB\] = 50 μM. The solid line is a least-squares fit to Eq. (1) \[17\]; the parameters of the fit are *K*~*i*~= 0.27 ± 0.01 μM and *k*~2~= (2.0 ± 0.2) × 10^-3^s^-1^. B: % activity of CEase vs. the time period for inhibition of the enzyme with (1R, αR)-**1**(50 nM) in the absence and presence of TFA (2 μM). \[PNPB\] = 50 μM. All the procedures followed those of Hosie et al. \[17\]. For the control experiments (squares), CEase was incubated alone at 25.0°C for a period of time before the inhibition reaction (CEase + PNPB + (1R, αR)-**1**). For the carbamate inhibition experiments (triangles), CEase was incubated with (1R, αR)-**1**(50 nM) at 25.0°C for a period of time before the enzyme reaction (CEase + PNPB). For the protection experiments (circles), CEase was incubated with (1R, αR)-**1**(50 nM) and TFA (2 μM) at 25.0°C for a period of time before the enzyme reaction (CEase + PNPB).](1471-2091-6-17-4){#F4}

The inhibition data for CEase by the four diastereomers of **1**and the two enantiomers of **2**are summarized (Table [1](#T1){ref-type="table"}). The stereochemical preference of CEase for the binaphthyl moiety of **1**(R \> S, ca. 10 times) is the same as that for **2**\[[@B20],[@B22]\]. The stereoselectivity of CEase for the α-methylbenzyl moiety of **1**is also the R-form (2--3 times over S-form).

###### 

Inhibition constants for CEase-catalyzed hydrolysis of PNPB in the presence of the four diastereomers of 1 and the two enantiomers of 2

  Inhibitor         K~i~(μM)      k~2~(10^-3^s^-1^)   k~i~(10^3^M^-1^s^-1^)
  ----------------- ------------- ------------------- -----------------------
  (1R, αR)**-1**    0.20 ± 0.01   2.0 ± 0.2           10 ± 1
  (1R, gαS)**-1**   0.50 ± 0.03   2.0 ± 0.2           4.0 ± 0.4
  (1S, gαR)**-1**   2.0 ± 0.1     2.0 ± 0.2           1.0 ± 0.1
  (1S, gαS)**-1**   6.0 ± 0.4     1.8 ± 0.2           0.30 ± 0.03
  (R)**-2**^a^      0.8 ± 0.1     10 ± 1              12 ± 2
  (S)**-2**^a^      1.3 ± 0.1     6.0 ± 0.5           5.0 ± 0.6

^a^Taken from references \[20,22\].

Among the four diastereomers of **1**, (1R, αR)-**1**is the most potent inhibitor and its overall inhibitory potency (*k*~*i*~) is about the same as that of R-**2**(Table [1](#T1){ref-type="table"}). On the other hand, (1S, αS)-**1**is the least potent inhibitor of CEase and its overall inhibitory potency is about 17-fold lower than that of S-**2**. All *k*~2~values for the CEase inhibition by**1**are about the same (Table [1](#T1){ref-type="table"}).

Discussion
==========

According to the X-ray crystal structure, CEase-catalyzed hydrolysis of cholesteryl linoleate has been proposed (Figure [1](#F1){ref-type="fig"}) \[[@B30],[@B31]\]. Like most carbamates, the four diastereomers of **1**are characterized as the pseudo substrate inhibitors of CEase (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}) \[[@B16]-[@B29]\] and meet some of the criteria proposed by Abeles and Maycock \[[@B38]\]. Therefore, the CEase inhibition by the four diastereomers of **1**is proposed (Figure [5](#F5){ref-type="fig"}) \[[@B4]\]. In this mechanism, the α-methylbenzylcarbamyl moiety of **1**is proposed to bind to ABS of the enzyme, and the binaphthyl moiety of **1**is proposed to bind to LBS of the enzyme. The stereochemical preference of CEase for the binaphthyl moiety of **1**(1R \> 1S in Table [1](#T1){ref-type="table"}) at LBS of the enzyme is therefore identical to that of **2**(R \> S) due to the fact that the nucleophilic attack of the Ser194 of the enzyme to the carbonyl group of the inhibitor sterically hinder from one of the naphthyl group of the inhibitors (Figure [5A](#F5){ref-type="fig"}) \[[@B20],[@B22]\]. Since 4-nitrophenyl-*N*-benzyl-carbamate is a very potent pseudo substrate inhibitor of CEase \[[@B21],[@B25],[@B26]\], the benzylcarbamyl moiety of the inhibitor is believed to bind tightly to ABS of the enzyme. Similarly, the α-methylbenzylcarbamyl moiety of **1**is also believed to bind to ABS of the enzyme. The stereochemical preference of CEase for the α-methylbenzylcarbamyl moiety of **1**at ABS of the enzyme is also R \> S (αR \> αS in Table [1](#T1){ref-type="table"}). The possible reason for this is the fact that one of the naphthyl group and the α-methyl group of (1S, αS)-**1**are located at the same side of the nucleophilic attack of Ser194 when the inhibitor binds to CEase and therefore these two groups of the inhibitor sterically hinder the nucleophilic attack of Ser194 to the inhibitor (Figure [5A](#F5){ref-type="fig"}). On the other hand, (1R, αR)-**1**does not have any hindrance for the nucleophilic attack of Ser194 (Figure [5B](#F5){ref-type="fig"}) and therefore (1R, αR)-**1**is the most potent inhibitor among the four diastereomers of **1**(Table [1](#T1){ref-type="table"}).

![Possible interactions between the stereoisomers of **1**and CEase \[31,31\]. (A) CEase and (1S, αS)-**1**. The methyl benzyl moiety of the inhibitor binds to ABS of the enzyme. Three unfavorable repulsions (in red) from the methyl moiety and Ser194, the naphthyl moiety and Ser194, and the naphthyl moiety and His435 hinder the nucleophilic attack of Ser194 to the carbonyl group of the inhibitor. (B) CEase and (1R, αR)-**1**. There is no unfavorable repulsion for the nucleophilic attack of Ser194 to the carbonyl group of the inhibitor.](1471-2091-6-17-5){#F5}

The stereoselectivity of CEase at ABS of the enzyme for the α-methylbenzyl group of **1**(R \> S) (Table [1](#T1){ref-type="table"}) is the same as that of CRL at its ABS for 2-methyl-6-(2-thienyl) hexanate \[[@B39]\]. For the *K*~*i*~step (Figure [3](#F3){ref-type="fig"}), ([1R](#F1){ref-type="fig"}, αR)-**1**and (1S, αR)-**1**bind to CEase 2.5 and 3 times more tightly than (1R, αS)-1 and (1S, αS)-1, respectively. The *K*~*i*~value with regard to the chiral center at the α-position of **1**is quite low compared to that with regard to the binaphthol chiral axis of **1**(Table [1](#T1){ref-type="table"}) \[[@B20],[@B22]\] and to that with regard to the phosphorus chiral center of isomalathion \[[@B13]\]. Therefore, we propose that ABS of CEase does not show high selectivity for the chiral acyl group due to a narrow and hydrophobic binding pocket for ABS \[[@B30],[@B31]\], which selectively and tightly binds to the benzyl phenyl moiety of the inhibitor and results in the discrimination of stereoselectivity by either the hydrogen atom or the methyl group at the α-position of the four diastereomers of **1**(Figure [5](#F5){ref-type="fig"}).

(1R, αR)-**1**and (1R, αS)-**1**are bound to CEase 10 and 12 times more tightly than (1S, αR)-1 and (1S, αS)-1, respectively (Table [1](#T1){ref-type="table"}); however, R-**2**is bound to CEase only 1.6 times more tightly than S-**2**\[[@B20],[@B22]\]. The possible reason is that the binding of the phenyl moiety of the α-methylbenzylcarbamyl group of **1**to ABS (Figure [5](#F5){ref-type="fig"}) constrains the binaphthol moiety of **1**to a more favorable conformation to bind with LBS, on the other hand, the *n*-butyl carbamyl of **2**has lots of room to \"breathe\" in ABS and therefore the binaphthol moiety of**2**has many conformations and results in loosely binding to LBS.

The *k*~2~values for the four diastereomers of **1**are about the same. This means that the *k*~2~step is insensitive to the stereochemistry of **1**. In other words, the stereoselectivity of CEase for (1R, αR)-**1**primarily results from the *K*~*i*~step. The *k*~2~values for all diastereomers of**1**are lower than those for the two atropisomers of **2**(Table [1](#T1){ref-type="table"}). The possible reason is that the *n*-butylcarbamyl enzyme from both atropisomers of **2**is relatively more stable than the α-methylbenzylcarbamyl enzymes from the four diastereomers of **1**.

Overall, we report that CEase has two stereoselective binding sites at LBS and ABS for the four diastereomers of **1**. CEase \[[@B13]\], *Chromobacterium viscosum*lipase, and *Rhizopus oryzal*lipase \[[@B40]\] also show two stereoselective binding sites at LBS and ES for organic phosphorus compounds. Therefore, it is possible that CEase and lipase may contain totally three stereoselective binding sites at ABS, ES, and LBS for the six diastereomers of substrates or inhibitors.

Conclusion
==========

Four diastereomers of **1**are synthesized and characterized as the pseudo substrate inhibitors of pancreatic cholesterol esterase. The inhibitory potencies for these four diastereomeric inhibitors are in the descending order of (1R, αR)-**1**, (1R, αS)-**1**, (1S, αR)-**1**, and (1S, αS)-**1**. The enzyme stereospecificity toward the 1, 1\'-bi-2-naphthyl moiety of the inhibitors is the R-form and is the same as that for **2**. The enzyme stereospecificity toward the α-methylbenzylcarbamyl moiety of the inhibitors is also R-form. For the first time, we observe that the acyl binding site of cholesterol esterase shows stereospecificity for diastereomeric inhibitors.

Methods
=======

Materials
---------

Porcine pancreatic CEase (ca. 70% pure since the observed *K*~*m*~value for this enzyme catalyzed hydrolysis of PNPB is 1.4 times higher than that for the pure enzyme \[[@B17]\]) and PNPB were obtained from Sigma; TFA and other chemicals were obtained from Aldrich. Silica gel used in liquid chromatography (Licorpre Silica 60, 200--400 mesh), medium pressure liquid chromatography column (LiChroprep Si 60) and thin layer chromatography plates (Kieselgel 60 F254) were obtained from Merck. An UV lamp as well as an UV detector (Linear UV-106 or ISCO UA-6) was used in detection. Hexane-ethyl acetate solvent gradient was used in liquid chromatography and medium pressure liquid chromatography. Other chemicals were of the highest quality available commercially. Carbamates **2**were synthesized as described before \[[@B20],[@B22]\].

Instrumental methods
--------------------

^1^H and ^13^C NMR spectra were recorded at 300 and 75.4 MHz (Varian-VXR 300 spectrometer), respectively. The ^1^H and ^13^C NMR chemical shifts were referred to internal Me~4~Si. UV spectra were recorded on an UV-visible spectrophotometer (Hewlett Packard 8452A or Beckman DU-650) with a cell holder circulated with a water bath. High resolution mass spectra were recorded at 70 eV on a Joel JMS-SX/SX-102A mass spectrophotometer. Elemental analyses were preformed on a Heraeus instrument.

Synthesis of four diastereomers of **1**
----------------------------------------

(1R, αR)-**1**, (1R, αS)-**1**, (1S, αR)-**1**, and (1S, αS)-**1**(Figure [2](#F2){ref-type="fig"}) were prepared from the condensation of R-(+)- or S-(-)-α-methylbenzyl isocyanate (\[α\]^20^~*D*~= +10° or -10°) with 1 equivalent of R-(+)- or S-(-)-1, 1\'-bi-2-naphthol (\[α\]^20^~*D*~= +34° or -34°) in the presence of a catalytic amount of pyridine in CH~2~Cl~2~at 25°C for 24 h (80--95 % yield). All products were purified by liquid chromatography or medium pressure liquid chromatography (silica gel, hexane-ethyl acetate) and characterized by ^1^H and ^13^C NMR spectra and high resolution mass spectra.

(1R, αR)-**1**, (1R, αS)-**1**, (1S, αR)-**1**, and (1S, αS)-**1**: ^1^H NMR (CDCl~3~, 300 MHz) δ/ppm 1.02 (d, J = 6.6 Hz, 3H, CH(Ph)CH~3~), 4.48 (quintet, J = 7 Hz, 1H, CH(Ph)CH~3~), 5.27 (d, J = 8.1 Hz, 1H, NH), 7.07--8.06 (m, 17H, aromatic H); ^13^C NMR (CDCl~3~, 75.4 MHz) δ/ppm 21.88 (CH3), 50.36 (CH(Ph)CH~3~), 122.45, 123.51, 125.43, 125.69, 126.08, 126.48, 126.60, 127.10, 127.24, 127.91, 128.18, 128.37, 128.53, 129.40, 131.40, 133.30, 133.41, 142.98, and 147.20 (aromatic Cs), 153.91 (C = O); High resolution mass spectra: Found: 433.1674; C~29~H~23~NO~3~requires 433.1678. \[α\]^25^~*D*~= +40, +21, -21, and -41° for (1R, αR)-**1**, (1R, αS)-**1**, (1S, αR)-**1**, and (1S, αS)-**1**, respectively. The stability of these compounds is very high at -20°C (no significant change for the optical rotation in 1 month).

Enzyme kinetics and data reduction
----------------------------------

All kinetic data were obtained by using an UV-visible spectrophotometer that was interfaced to a computer. Microcal Origin (version 6.0) was used for all least squares curve fittings. The CEase inhibition was assayed as described in Hosie et al. \[[@B17]\]. The temperature was maintained at 25.0°C by a refrigerated circulating water bath. All reactions were performed in sodium phosphate buffer (pH 7.0) containing NaCl (0.1 M), acetonitrile (2% by volume), substrate PNPB (50 μM), triton X-100 (0.5 % by weight) and varying concentration of inhibitors (from 0.1 to 10 μM). The *K*~*m*~value for CEase-catalyzed hydrolysis of PNPB was calculated to be 140 ± 10 μM from the Michaelis-Menten equation. Requisite volumes of stock solution of substrate and inhibitors in acetonitrile were injected into reaction buffers via a pipet. CEase was dissolved in sodium phosphate buffer (0.1 M, pH 7.0). Reactions were initiated by injecting enzyme and monitored at 410 nm on the UV-visible spectrometer. First-order rate constants (the *k*~app~values) for inhibition of CEase were determined as described by Hosie et al. \[[@B17]\] Values of *K*~*i*~and *k*~2~can be obtained by the parameters of non-linear least squares curve fittings of *k*~app~vs. \[I\] plot to Equation (1) (Figure [4A](#F4){ref-type="fig"}). Duplicate sets of data were collected for each inhibitor concentration.
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